Genetic screening in sporadic ALS and FTD
暂无分享,去创建一个
J. Rowe | A. Al-Chalabi | A. Chiò | O. Hardiman | J. Rohrer | M. Turner | K. Talbot | M. Kiernan | W. Seeley | M. Turner | William Seeley | William W. Seeley
[1] S. Kolb,et al. Genetic testing and genetic counseling for amyotrophic lateral sclerosis: an update for clinicians , 2016, Genetics in Medicine.
[2] A. Al-Chalabi,et al. Gene discovery in amyotrophic lateral sclerosis: implications for clinical management , 2017, Nature Reviews Neurology.
[3] A. Chiò,et al. Use of Genetic Testing in Amyotrophic Lateral Sclerosis by Neurologists , 2017, JAMA neurology.
[4] Annelot M. Dekker,et al. Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosis , 2016, Nature Genetics.
[5] J. Hodges,et al. The frontotemporal dementia-motor neuron disease continuum , 2016, The Lancet.
[6] O. Hardiman,et al. Aggregation of neurologic and neuropsychiatric disease in amyotrophic lateral sclerosis kindreds: A population‐based case–control cohort study of familial and sporadic amyotrophic lateral sclerosis , 2013, Annals of neurology.
[7] A. Chiò,et al. Genetic counselling in ALS: facts, uncertainties and clinical suggestions , 2013, Journal of Neurology Neurosurgery & Psychiatry.
[8] C. van Broeckhoven,et al. Distinct clinical characteristics of C9orf72 expansion carriers compared with GRN, MAPT, and nonmutation carriers in a Flanders-Belgian FTLD cohort. , 2013, JAMA neurology.
[9] Janel O. Johnson,et al. Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study , 2012, The Lancet Neurology.
[10] O. Hardiman,et al. Absence of consensus in diagnostic criteria for familial neurodegenerative diseases , 2012, Journal of Neurology, Neurosurgery & Psychiatry.
[11] K. Talbot. Familial versus sporadic amyotrophic lateral sclerosis--a false dichotomy? , 2011, Brain : a journal of neurology.
[12] Bruce L. Miller,et al. Expanded GGGGCC Hexanucleotide Repeat in Noncoding Region of C9ORF72 Causes Chromosome 9p-Linked FTD and ALS , 2011, Neuron.
[13] David Heckerman,et al. A Hexanucleotide Repeat Expansion in C9ORF72 Is the Cause of Chromosome 9p21-Linked ALS-FTD , 2011, Neuron.
[14] A. Al-Chalabi,et al. The risk to relatives of patients with sporadic amyotrophic lateral sclerosis , 2011, Brain : a journal of neurology.
[15] C. Lewis,et al. Modelling the Effects of Penetrance and Family Size on Rates of Sporadic and Familial Disease , 2011, Human Heredity.
[16] O. Hardiman,et al. Proposed criteria for familial amyotrophic lateral sclerosis , 2011, Amyotrophic Lateral Sclerosis.
[17] O. Hardiman,et al. Rate of familial amyotrophic lateral sclerosis: a systematic review and meta-analysis , 2010, Journal of Neurology, Neurosurgery & Psychiatry.
[18] A. Farmer,et al. Chromosome 9p21 in sporadic amyotrophic lateral sclerosis in the UK and seven other countries: a genome-wide association study , 2010, The Lancet Neurology.
[19] J. Lowe,et al. Juvenile ALS with basophilic inclusions is a FUS proteinopathy with FUS mutations , 2010, Neurology.
[20] Ewout J N Groen,et al. Genome-wide association study identifies 19p13.3 (UNC13A) and 9p21.2 as susceptibility loci for sporadic amyotrophic lateral sclerosis , 2009, Nature Genetics.
[21] Bruce L. Miller,et al. Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis , 2006, Science.
[22] F. Baas,et al. Familial amyotrophic lateral sclerosis with frontotemporal dementia is linked to a locus on chromosome 9p13.2-21.3. , 2006, Brain : a journal of neurology.
[23] H. Horvitz,et al. A locus on chromosome 9p confers susceptibility to ALS and frontotemporal dementia , 2006, Neurology.
[24] L. Barbeito,et al. A role for astrocytes in motor neuron loss in amyotrophic lateral sclerosis , 2004, Brain Research Reviews.
[25] R. Andorno,et al. The right not to know: an autonomy based approach , 2004, Journal of Medical Ethics.
[26] Orla Hardiman,et al. “True” sporadic ALS associated with a novel SOD‐1 mutation , 2002, Annals of neurology.